Microbot Medical Inc buy The Goldman Sachs Group, Inc.
Start price
24.01.24
/
50%
€1.17
Target price
24.01.25
€5.51
Performance (%)
-26.24%
Price
07.08.24
€0.86
Summary
This prediction is currently active. The price of Microbot Medical Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.24%. This prediction currently runs until 24.01.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Microbot Medical Inc | -10.252% | -10.252% |
iShares Core DAX® | -5.630% | -5.765% |
iShares Nasdaq 100 | -8.559% | -13.005% |
iShares Nikkei 225® | -9.576% | -9.058% |
iShares S&P 500 | -6.631% | -7.103% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Microbot Medical Inc diskutieren
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat